BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 11935163)

  • 1. Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation.
    Goffin E; Devogelaer JP; Lalaoui A; Depresseux G; De Naeyer P; Squifflet JP; Pirson Y; van Ypersele de Strihou C
    Transpl Int; 2002 Mar; 15(2-3):73-80. PubMed ID: 11935163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bone mineral density after renal transplantation under a tacrolimus-based immunosuppression: a pilot study.
    Goffin E; Devogelaer JP; Depresseux G; Squifflet JP; Pirson Y; van Yperselede de Strihou C
    Clin Nephrol; 2003 Mar; 59(3):190-5. PubMed ID: 12653262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: a four-year prospective study.
    Marcén R; Caballero C; Pascual J; Teruel JL; Tenorio M; Ocaña J; Villafruela JJ; Burgos FJ; Fernández AM; Muriel A; Ortuño J
    Transplantation; 2006 Mar; 81(6):826-31. PubMed ID: 16570003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation.
    Yun YS; Kim BJ; Hong SP; Lee TW; Lim CG; Kim MJ
    Transplant Proc; 1996 Jun; 28(3):1561-4. PubMed ID: 8658786
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lumbar bone mineral density after kidney transplantation: a three-year prospective study.
    Marcén R; Caballero C; Galeano C; Pascual J; Ocaña J; Tenorio M; Echarri R; Tabernero G; Villafruela JJ; Burgos FJ; Ortuño J
    Transplant Proc; 2005 Apr; 37(3):1466-7. PubMed ID: 15866641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of tacrolimus vs cyclosporin-A on bone metabolism after kidney transplantation: a cross-sectional study in 28 patients].
    Albano L; Casez JP; Bekri S; Gigante M; Champenois I; Cassuto-Viguier E; Jaeger P
    Nephrol Ther; 2005 May; 1(2):115-20. PubMed ID: 16895674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
    Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
    Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation.
    Giannini S; D'Angelo A; Carraro G; Antonello A; Di Landro D; Marchini F; Plebani M; Zaninotto M; Rigotti P; Sartori L; Crepaldi G
    Clin Nephrol; 2001 Nov; 56(5):353-63. PubMed ID: 11758005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term bone loss after renal transplantation: comparison of immunosuppressive regimens.
    McIntyre HD; Menzies B; Rigby R; Perry-Keene DA; Hawley CM; Hardie IR
    Clin Transplant; 1995 Feb; 9(1):20-4. PubMed ID: 7742578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bone mineral density and selected metabolic parameters over 24 months following renal transplantation.
    Al-Gabri S; Zadrazil J; Krejcí K; Horák P; Bachleda P
    Transplant Proc; 2005 Mar; 37(2):1014-9. PubMed ID: 15848609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of bone disease at 2 years after transplantation: a single-center study.
    Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural skeletal impairment induced by immunosuppressive therapy in rats: cyclosporine A vs tacrolimus.
    Abdelhadi M; Ericzon BG; Hultenby K; Sjöden G; Reinholt FP; Nordenström J
    Transpl Int; 2002 Apr; 15(4):180-7. PubMed ID: 11976740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone histopathology and densitometry comparison between cyclosporine a monotherapy and prednisolone plus azathioprine dual immunosuppression in renal transplant patients.
    Cueto-Manzano AM; Konel S; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R; Hutchison AJ
    Transplantation; 2003 Jun; 75(12):2053-8. PubMed ID: 12829911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiresorptive therapy in asthmatic patients receiving high-dose inhaled steroids: a prospective study for 18 months.
    Wang WQ; Ip MS; Tsang KW; Lam KS
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):445-50. PubMed ID: 9564795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations between leptin, body composition, bone mineral density, and bone metabolism in kidney transplant recipients.
    Malyszko J; Malyszko JS; Pawlak K; Konstantynowicz J; Wolczynski S; Kaczmarski M; Mysliwiec M
    Transplant Proc; 2005 Jun; 37(5):2151-3. PubMed ID: 15964364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term evolution of body composition after renal transplantation: 5-year survey.
    Moreau K; Chauveau P; Martin S; El-Haggan W; Barthe N; Merville P; Aparicio M
    J Ren Nutr; 2006 Oct; 16(4):291-9. PubMed ID: 17046612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.
    Karner I; Hrgović Z; Sijanović S; Buković D; Klobucar A; Usadel KH; Fassbender WJ
    Eur J Med Res; 2005 Nov; 10(11):480-8. PubMed ID: 16354602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.